Ruixiang Xia

506 total citations
25 papers, 239 citations indexed

About

Ruixiang Xia is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Ruixiang Xia has authored 25 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Hematology. Recurrent topics in Ruixiang Xia's work include Chronic Lymphocytic Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and CAR-T cell therapy research (3 papers). Ruixiang Xia is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and CAR-T cell therapy research (3 papers). Ruixiang Xia collaborates with scholars based in China. Ruixiang Xia's co-authors include Xiaoliang Xu, Lixin Zhu, Qinhua Liu, Qingshu Zeng, Bin Zhang, Jiangluqi Song, Xiaodong Li, Hao Wang, Tongtong Jiang and Linlin Wu and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Applied Materials & Interfaces and Frontiers in Immunology.

In The Last Decade

Ruixiang Xia

23 papers receiving 237 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruixiang Xia China 10 85 58 52 48 45 25 239
Huifang Huang China 10 151 1.8× 60 1.0× 57 1.1× 57 1.2× 30 0.7× 39 362
Laura R. Pageon United States 8 150 1.8× 58 1.0× 47 0.9× 57 1.2× 9 0.2× 12 298
Yu Lei China 6 146 1.7× 39 0.7× 102 2.0× 22 0.5× 62 1.4× 10 351
Jingzhe Wang China 10 191 2.2× 70 1.2× 130 2.5× 73 1.5× 20 0.4× 16 405
Sushant Tripathy United States 5 196 2.3× 34 0.6× 139 2.7× 74 1.5× 23 0.5× 8 407
Yimei Que China 8 109 1.3× 73 1.3× 17 0.3× 60 1.3× 8 0.2× 16 229
Lianke Liu China 11 165 1.9× 94 1.6× 109 2.1× 56 1.2× 51 1.1× 27 361
Sara M. Radwan Egypt 11 72 0.8× 55 0.9× 19 0.4× 37 0.8× 5 0.1× 27 262
Shan Wu China 11 178 2.1× 53 0.9× 65 1.3× 81 1.7× 8 0.2× 34 331

Countries citing papers authored by Ruixiang Xia

Since Specialization
Citations

This map shows the geographic impact of Ruixiang Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruixiang Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruixiang Xia more than expected).

Fields of papers citing papers by Ruixiang Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruixiang Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruixiang Xia. The network helps show where Ruixiang Xia may publish in the future.

Co-authorship network of co-authors of Ruixiang Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Ruixiang Xia. A scholar is included among the top collaborators of Ruixiang Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruixiang Xia. Ruixiang Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bao, Jing, et al.. (2024). N6-methyladenosine-induced miR-182-5p promotes multiple myeloma tumorigenesis by regulating CAMK2N1. Molecular and Cellular Biochemistry. 479(11). 3077–3089. 3 indexed citations
2.
Hong, Jian, Leiming Xia, Xiaodong Yuan, et al.. (2022). TIM-3 Expression Level on AML Blasts Correlates With Presence of Core Binding Factor Translocations Rather Than Clinical Outcomes. Frontiers in Oncology. 12. 879471–879471. 3 indexed citations
3.
Liu, Qinhua, Xiaonan Wang, Mingyue Song, et al.. (2022). LncRNA FIRRE stimulates PTBP1‐induced Smurf2 decay, stabilizes B‐cell receptor, and promotes the development of diffuse large B‐cell lymphoma. Hematological Oncology. 40(4). 554–566. 9 indexed citations
4.
Luan, Chengxin, Haixia Wang, Junjie Zhou, et al.. (2022). Delayed Diagnosis and Multi-TKI Intolerance: A Case Report of CML Concurrent With COVID-19. Frontiers in Oncology. 12. 921587–921587.
5.
6.
Hong, Jian, et al.. (2021). Long non-coding RNA CRNDE suppressing cell proliferation is regulated by DNA methylation in chronic lymphocytic leukemia. Leukemia Research. 105. 106564–106564. 15 indexed citations
7.
8.
Wu, Linlin, Liang Xia, Xiaowen Chen, et al.. (2021). Long non-coding RNA LINC01003 suppresses the development of multiple myeloma by targeting miR-33a-5p/PIM1 axis. Leukemia Research. 106. 106565–106565. 15 indexed citations
9.
Wu, Linlin, Liang Xia, Huimin Jiang, et al.. (2021). Long non‑coding RNA DANCR represses the viability, migration and invasion of multiple myeloma cells by sponging miR‑135b‑5p to target KLF9. Molecular Medicine Reports. 24(3). 16 indexed citations
10.
11.
Chen, Xiaowen, et al.. (2020). <p>Inhibition of Skp2 Sensitizes Chronic Myeloid Leukemia Cells to Imatinib</p>. Cancer Management and Research. Volume 12. 4777–4787. 4 indexed citations
12.
Liu, Qinhua, et al.. (2017). Clinical significance of measuring reticulated platelets in infectious diseases. Medicine. 96(52). e9424–e9424. 20 indexed citations
13.
Chen, Chen, Siyu Yang, Jing Yu, et al.. (2017). Numerical study on tunable perfect absorption in square graphene-dielectric arrays at near-infrared wavelengths. Materials & Design. 128. 157–165. 9 indexed citations
14.
15.
Ge, Jian, Min Ruan, Lingyan Zhu, et al.. (2015). [Study on the relationship of platelet specific-autoantibodies with therapeutic outcomes by dexamethasone in immune thrombocytopenia purpura].. PubMed. 36(3). 202–5. 1 indexed citations
16.
Jiang, Tongtong, Jiangluqi Song, Bin Zhang, et al.. (2015). Au–Ag@Au Hollow Nanostructure with Enhanced Chemical Stability and Improved Photothermal Transduction Efficiency for Cancer Treatment. ACS Applied Materials & Interfaces. 7(39). 21985–21994. 55 indexed citations
17.
Xu, Zhe, Sumei Zhang, Qing Zhou, Yuan Wang, & Ruixiang Xia. (2014). Endocan, a potential prognostic and diagnostic biomarker of acute leukemia. Molecular and Cellular Biochemistry. 395(1-2). 117–123. 17 indexed citations
18.
19.
Hu, Xueying, et al.. (2011). [Mechanism of apoptosis in human leukemia NB4 cells induced by total astragalosides].. PubMed. 33(5). 345–8. 8 indexed citations
20.
Xia, Ruixiang. (2009). Empirical Study of Bone Marrow Mesenchymal Stem Cell Treating Aplastic Anemia. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huifang Huang Breakdown of academic impact, for papers by Laura R. Pageon Breakdown of academic impact, for papers by Yu Lei Breakdown of academic impact, for papers by Jingzhe Wang Breakdown of academic impact, for papers by Sushant Tripathy Breakdown of academic impact, for papers by Yimei Que Breakdown of academic impact, for papers by Lianke Liu Breakdown of academic impact, for papers by Sara M. Radwan Breakdown of academic impact, for papers by Shan Wu
Rankless by CCL
2026